| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3870854 | The Journal of Urology | 2010 | 6 Pages |
Abstract
A prostate specific antigen velocity threshold of 0.4 ng/ml per year was associated with the likelihood of insignificant prostate cancer. This suggests that prostate specific antigen velocity may be a useful adjunct in prostate cancer screening to increase specificity for identifying patients with clinically significant disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stacy Loeb, Kimberly A. Roehl, Brian T. Helfand, Donghui Kan, William J. Catalona,